BreAX Biotech
Breax is a biotechnology company specializing in the development of a non-invasive, accurate, convenient, and low-cost screening and diagnosis solution for diseases using exhaled breath analysis. Their core product is a precise detection and analysis platform for volatile organic compounds (VOCs) in human breath, combining hardware (mass spectrometer) and AI-powered software. The company aims to revolutionize early disease detection and precision medicine, particularly for cancer and infectious diseases, with results available in one minute. Breax has a strong focus on research and development, evidenced by their partnerships with top hospitals and a growing database of breath samples.
BreAX Biotech
Breax is a biotechnology company specializing in the development of a non-invasive, accurate, convenient, and low-cost screening and diagnosis solution for diseases using exhaled breath analysis. Their core product is a precise detection and analysis platform for volatile organic compounds (VOCs) in human breath, combining hardware (mass spectrometer) and AI-powered software. The company aims to revolutionize early disease detection and precision medicine, particularly for cancer and infectious diseases, with results available in one minute. Breax has a strong focus on research and development, evidenced by their partnerships with top hospitals and a growing database of breath samples.